Compare PRFX & TNON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRFX | TNON |
|---|---|---|
| Founded | 2007 | 2012 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6M | 2.8M |
| IPO Year | 2020 | 2021 |
| Metric | PRFX | TNON |
|---|---|---|
| Price | $0.88 | $3.77 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $44.38 |
| AVG Volume (30 Days) | 258.6K | ★ 9.9M |
| Earning Date | 09-03-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 84.90 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,944,000.00 |
| Revenue This Year | N/A | $46.86 |
| Revenue Next Year | N/A | $63.99 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 20.35 |
| 52 Week Low | $0.58 | $0.13 |
| 52 Week High | $5.39 | $17.84 |
| Indicator | PRFX | TNON |
|---|---|---|
| Relative Strength Index (RSI) | 38.52 | 50.09 |
| Support Level | $0.60 | $0.52 |
| Resistance Level | $1.25 | $7.15 |
| Average True Range (ATR) | 0.09 | 0.32 |
| MACD | -0.00 | -0.03 |
| Stochastic Oscillator | 2.06 | 42.42 |
PRF Technologies Ltd is a a diversified platform spanning speciality pharmaceuticals, drug-delivery technologies, and AI-driven renewable-energy analytics. PRF Technologies focuses on pharmaceutical therapies that emphasize reformulation and sustained-release drug-delivery technologies and AI-driven energy analytics. PRF-110, the company's lead product, is based on the local anesthetic ropivacaine and targets the postoperative pain relief market. The company has two operating segments composed of the Clinical Development segment, which facilitates the development of potential new drug compounds, and the Solar segment, which comprises the design and development of the company's intellectual property and the sale related service offerings.
Tenon Medical Inc is a medical device company that has minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.